Acurx Pharmaceuticals (ACXP) vs Apimeds Pharmaceuticals US (APUS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($7.0 million vs $7.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACXP | APUS |
|---|---|---|
| Share price | $1.26 | $4.65 |
| Market cap | $7.00M | $7.02M |
| 1-day change | +0.80% | -15.61% |
| YTD return | — | -66.40% |
| 1-year return | — | -70.53% |
| EPS (TTM) | $-2.67 | $-36.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.98 | $59.70 |
| 52-week low | $1.23 | $1.51 |
| Distance from 52-week high | -84.21% | -92.21% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1249.21% | — |
| Average volume | 125.08K | 3.67M |
| Shares outstanding | 5.56M | 1.51M |
| Employees | 4 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Acurx Pharmaceuticals
ACXP stock →Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
ACXP vs APUS FAQ
Which is bigger, Acurx Pharmaceuticals or Apimeds Pharmaceuticals US?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $7.02M compared with $7.00M for Acurx Pharmaceuticals (ACXP).
Are Acurx Pharmaceuticals and Apimeds Pharmaceuticals US in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.